Found: 68
Select item for more details and to access through your institution.
Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Biological vs Conventional Combination Treatment andWork Loss in Early Rheumatoid Arthritis A Randomized Trial.
- Published in:
- JAMA Internal Medicine, 2013, v. 173, n. 15, p. 1407, doi. 10.1001/jamainternmed.2013.7801
- By:
- Publication type:
- Article
Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.899372
- By:
- Publication type:
- Article
Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden.
- Published in:
- International Journal of Technology Assessment in Health Care, 2010, v. 26, n. 1, p. 54, doi. 10.1017/S0266462309990596
- By:
- Publication type:
- Article
Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00902
- By:
- Publication type:
- Article
Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics‐Driven Machine Learning Approach.
- Published in:
- Arthritis Care & Research, 2022, v. 74, n. 6, p. 879, doi. 10.1002/acr.24834
- By:
- Publication type:
- Article
Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity and the Probability of Achieving Low Disease Activity at Month 6.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Choosing Wisely in Daily Practice: An Intervention Study on Antinuclear Antibody Testing by Rheumatologists.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment Algorithms in Systemic Lupus Erythematosus.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1049-3
- By:
- Publication type:
- Article
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-0951-z
- By:
- Publication type:
- Article
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, p. 1, doi. 10.1186/s13075-015-0841-9
- By:
- Publication type:
- Article
Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 181, doi. 10.1186/s13075-015-0707-1
- By:
- Publication type:
- Article
Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis - a probabilistic approach.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 5, p. 1, doi. 10.1186/s13075-014-0448-6
- By:
- Publication type:
- Article
Integrated safety in tocilizumab clinical trials.
- Published in:
- Arthritis Research & Therapy, 2011, v. 13, n. 5, p. 1, doi. 10.1186/ar3455
- By:
- Publication type:
- Article
Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
LONGTERM SAFETY OF PATIENTS RECEIVING RITUXIMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS.
- Published in:
- Romanian Journal of Rheumatology / Revista Romana de Reumatologie, 2010, v. 19, n. 1, p. 20
- By:
- Publication type:
- Article
Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials.
- Published in:
- Rheumatology, 2023, v. 62, n. 4, p. 1526, doi. 10.1093/rheumatology/keac491
- By:
- Publication type:
- Article
ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis? A longitudinal study in four arthralgia cohorts.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4892, doi. 10.1093/rheumatology/keac239
- By:
- Publication type:
- Article
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4752, doi. 10.1093/rheumatology/keac185
- By:
- Publication type:
- Article
A neutrophil signature is strongly associated with increased cardiovascular risk in gout.
- Published in:
- Rheumatology, 2021, v. 60, n. 6, p. 2783, doi. 10.1093/rheumatology/keaa712
- By:
- Publication type:
- Article
Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
- Published in:
- Rheumatology, 2021, v. 60, n. 1, p. 207, doi. 10.1093/rheumatology/keaa267
- By:
- Publication type:
- Article
Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension.
- Published in:
- Rheumatology, 2020, v. 59, n. 2, p. 281, doi. 10.1093/rheumatology/kez279
- By:
- Publication type:
- Article
Assessing joint inflammation—a way forward for SLE trials?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
The relationship between remission and health-related quality of life in a cohort of SLE patients.
- Published in:
- Rheumatology, 2019, v. 58, n. 4, p. 628, doi. 10.1093/rheumatology/key349
- By:
- Publication type:
- Article
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 6, p. 1031, doi. 10.1093/rheumatology/kev442
- By:
- Publication type:
- Article
Long-term follow-up in lupus nephritis patients treated with rituximab—clinical and histopathological response.
- Published in:
- Rheumatology, 2013, v. 52, n. 5, p. 847, doi. 10.1093/rheumatology/kes348
- By:
- Publication type:
- Article
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study.
- Published in:
- Rheumatology, 2012, v. 51, n. 12, p. 2204, doi. 10.1093/rheumatology/kes150
- By:
- Publication type:
- Article
Ten years with biologics: to whom do data on effectiveness and safety apply?
- Published in:
- Rheumatology, 2011, v. 50, n. 1, p. 204, doi. 10.1093/rheumatology/keq326
- By:
- Publication type:
- Article
Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level.
- Published in:
- Rheumatology, 2010, v. 49, n. 11, p. 2098, doi. 10.1093/rheumatology/keq197
- By:
- Publication type:
- Article
Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.
- Published in:
- Rheumatology, 2010, v. 49, n. 8, p. 1502, doi. 10.1093/rheumatology/keq055
- By:
- Publication type:
- Article
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat3356
- By:
- Publication type:
- Article
Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort.
- Published in:
- International Journal of Rheumatology, 2018, p. 1, doi. 10.1155/2018/9152480
- By:
- Publication type:
- Article
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient Preference Assessment Reveals Disease Aspects Not Covered by Recommended Outcomes in Polymyositis and Dermatomyositis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Patient Preference Assessment Reveals Disease Aspects Not Covered by Recommended Outcomes in Polymyositis and Dermatomyositis.
- Published in:
- ISRN Rheumatology, 2011, p. 1, doi. 10.5402/2011/463124
- By:
- Publication type:
- Article
Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157961
- By:
- Publication type:
- Article
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1751, doi. 10.1002/art.40176
- By:
- Publication type:
- Article
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 953, doi. 10.1002/art.40019
- By:
- Publication type:
- Article
Editorial: Who Gets Lupus? Clues to a Tantalizing Syndrome.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 3, p. 483, doi. 10.1002/art.40005
- By:
- Publication type:
- Article
Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2184, doi. 10.1002/art.39682
- By:
- Publication type:
- Article
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2174, doi. 10.1002/art.39722
- By:
- Publication type:
- Article
VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 1, p. 46, doi. 10.1002/art.39473
- By:
- Publication type:
- Article